摘要
目的探讨肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效。方法将60例新生儿呼吸窘迫征患儿随机分为观察组和对照组,每组各30例,对照组给予保暖、吸痰、吸氧、控制感染、防治出血、机械通气等常规治疗,观察组在常规治疗的基础上应用肺表面活性物质治疗,观察两组患儿的发生率。结果观察组新生儿呼吸窘迫综合征的发生率低于对照组,差异有统计学意义(P<0.05)。结论肺表面活性物质治疗新生儿呼吸窘迫综合征患儿疗效显著,有显著的预防作用并可以减轻病情。
Objective Discuss the curative effect of pulmonary surfactant treating infants respiratory distress syndrome.Methods Divided into two groups stochastically 60 examples with infants respiratory distress syndrome,each group of 30 examples,the control group gives oxygen,control of infection,preventing and controlling hemorrhage,machinery ventilation conventional treatments and so on maintains warmth,attractd phlegm,the observation group applied the pulmonary surfactant,infants treatment in the conventional treatment foundation,observed two groups of trouble formation rates.Results There is statistics significance between two groups of infants respiratory distress syndrome formation rates,the observation group is lower than the control group(P0.05).Conclusion There is remarkable prevention function of pulmonary surfactant treating infants respiratory distress syndrome,and may reduce the condition.
出处
《实用心脑肺血管病杂志》
2011年第12期2025-2026,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease